Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress

Eleven clinical trial sites in BASECAMP currently active; remaining planned sites to be activated throughout Q2 2026 BASECAMP remains on track to complete enrollment in Q3 2026 The Company has initiated the TRAILHEAD study in the U.S. in adults aged 16-25 years. Current cash available of $69.9M (Cdn $97.5M) provides runway through 2027 TORONTO, May... The post Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress appeared first on Montreal Gazette .

Original source: Montreal Gazette